Welcome
Support Centre
13 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Ultrasound therapy for lateral epicondylitis. A double blind randomised placebo controlled trial
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN34475330
Date ISRCTN assigned12/09/2003
Local reference number(s)N0544103837
Public titleUltrasound therapy for lateral epicondylitis. A double blind randomised placebo controlled trial
Scientific title
AcronymN/A
Disease/condition/study domainMusculoskeletal Diseases: Lateral epicondylitis (tennis elbow)
Study hypothesisUltrasound therapy for lateral epicondylitis
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria200 18-75 year olds (PROJ)
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date11/09/2000
Anticipated end date11/09/2003
Status of trialCompleted
Target number of participants200
InterventionsTo evaluate the effects of ultrasound in the treatment of lateral epicondylitis. Adult subjects with lateral epicondylitis will be randomised to receive either ultrasound (US) or sham (S) therapy. In the US group pulsed ultrasound will be delivered at a standardised dosage, initially five times weekly for 3 weeks, then three times weekly for 3 weeks. A single machine will be used and calibrated twice daily. The patient, assessor and treating clinician will be blinded. Outcome measures will be recorded at 6 weeks and at 9 months from baseline. These will include a forearm evaluation score and pain (primary measures), grip strength, flexibility, inflammation (thermographic score), quality of life and general health status, a summary item of status of the injury and a follow up transition item.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingCambridge Consortium - Addenbrookes
Sponsor nameRecord provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Sponsor detailsThe Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44 (0)20 7307 2623
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.doh.gov.uk
Contact nameDr Cathy Speed
Contact detailsBox No 204
Department of Rheumatology
Addenbrooke's NHS Trust
Hills Road
Cambridge
United Kingdom
CB2 2QQ
Contact telephone+44 01223 586518
Contact fax+44
Contact emailcas50@medschl.cam.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN34475330
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central